Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05319028 |
| Title | Study of Mivavotinib (CB-659) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Calithera Biosciences, Inc |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Northwestern University | Evanston | Illinois | 60208 | United States | Details | |
| Henry Ford Health | Detroit | Michigan | 48202 | United States | Details | |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | United States | Details | |
| Toledo Clinic Cancer Center | Toledo | Ohio | 43623 | United States | Details | |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | United States | Details | |
| The University of Texas, M. D. Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| The University of Texas Health Science Center at San Antonio | San Antonio | Texas | 78229 | United States | Details |